| Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer (NCT03189446) | University of Oklahoma | 2017-10-02 |
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers (NCT03212404) | Checkpoint Therapeutics, Inc. | 2017-09-20 |
| Pembro/Carbo/Taxol in Endometrial Cancer (NCT02549209) | Daniela Matei, MD | 2017-08-22 |
| Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients (NCT03210129) | Luxembourg Institute of Health | 2017-07-06 |
| Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer (NCT03192059) | University Hospital, Ghent | 2017-07-01 |
| An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer (NCT03077698) | Xenetic Biosciences, Inc. | 2017-06-14 |
| Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? (NCT03207074) | Imperial College London | 2017-06-13 |
| Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? (NCT03207061) | Imperial College London | 2017-06-13 |
| Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? (NCT03207126) | Imperial College London | 2017-06-13 |
| Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer (NCT03099499) | Fox Chase Cancer Center | 2017-06-08 |
| Effectiveness of Care in Certified Cancer Centres in Germany (NCT04334239) | Technische Universität Dresden | 2017-05-01 |
| Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC) (NCT02566811) | University College, London | 2017-04-12 |
| Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer (NCT04302714) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2017-03-20 |
| Scale Down for Endometrial Cancer (NCT03169023) | Washington University School of Medicine | 2017-02-21 |
| A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer (NCT03015129) | Memorial Sloan Kettering Cancer Center | 2017-01-01 |
| Carboplatin-cyclophosphamide Combined With Atezolizumab (NCT02914470) | The Netherlands Cancer Institute | 2017-01-01 |
| Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer (NCT02730416) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2016-12-12 |
| A Study to Assess the Efficacy and Safety of ABTL0812 (NCT03366480) | Ability Pharmaceuticals SL | 2016-12-01 |
| Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors (NCT02988817) | Genmab | 2016-11-23 |
| A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer (NCT02922764) | Inspirna, Inc. | 2016-11-01 |
| Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer (NCT02943811) | Università degli Studi dell'Insubria | 2016-10-01 |
| Positron Emission Tomography (PET) Imaging Studies With NIS Reporter (NCT02907073) | Mayo Clinic | 2016-09-01 |
| HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life (NCT03000192) | University Hospital Southampton NHS Foundation Trust | 2016-08-01 |
| Endometrial Cancer Biomarker Changes Following Exposure to Metformin (NCT02042495) | Jewish General Hospital | 2016-08-01 |
| Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer (NCT02834988) | University of Miami | 2016-07-28 |
| A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus (NCT02744898) | NYU Langone Health | 2016-07-01 |
| Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding (NCT03330015) | Chinese University of Hong Kong | 2016-06-03 |
| Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers (NCT02725489) | Mary Crowley Medical Research Center | 2016-06-03 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers (NCT02638402) | National Taiwan University Hospital | 2016-05-01 |
| Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer (NCT02765698) | Mayo Clinic | 2016-05-01 |
| MR-HIFU for Recurrent Gynaecological Cancer (NCT02714621) | Institute of Cancer Research, United Kingdom | 2016-05-01 |
| Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine (NCT02774395) | Centre Hospitalier Universitaire de Nice | 2016-05-01 |
| Guangzhou Women's Health Cohort Study (GWHCS) (NCT05506800) | Guangzhou Women and Children's Medical Center | 2016-03-03 |
| SLNM in Endometrial Cancer Combined With OSNA (NCT02826291) | Charles University, Czech Republic | 2016-03-01 |
| Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer (NCT02990728) | Chang Gung Memorial Hospital | 2016-03-01 |
| MK-3475 Immunotherapy in Endometrial Carcinoma (NCT02630823) | Washington University School of Medicine | 2016-02-05 |
| Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003) (NCT04560491) | Ankara University | 2016-02-01 |
| Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation (NCT02658565) | Frederick R. Ueland, M.D. | 2016-01-29 |
| Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors (NCT02646748) | Incyte Corporation | 2016-01-25 |
| Cancer of the Uterus and Treatment of Stress Urinary Incontinence (NCT02667431) | Women and Infants Hospital of Rhode Island | 2016-01-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies (NCT02433626) | Critical Outcome Technologies Inc. | 2015-12-01 |
| Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification (NCT03171506) | University of Alabama at Birmingham | 2015-11-09 |
| Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (NCT02589366) | University of California, San Diego | 2015-11-01 |
| A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium (NCT02767362) | UNC Lineberger Comprehensive Cancer Center | 2015-11-01 |
| Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) (NCT02558348) | Advenchen Laboratories, LLC | 2015-11-01 |
| Biomarker Guided Treatment in Gynaecological Cancer (NCT02543710) | Haukeland University Hospital | 2015-10-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso (NCT02580747) | Chinese PLA General Hospital | 2015-10-01 |
| Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients (NCT02560571) | Meir Medical Center | 2015-10-01 |
| Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer (NCT05261165) | F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | 2015-10-01 |
| Role of Uterine Manipulator in Hysterectomy - Ro.Man.HY (NCT02762214) | Catholic University of the Sacred Heart | 2015-10-01 |
| Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive (NCT04290299) | National Cancer Institute, Naples | 2015-09-15 |
| ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More? (NCT02413606) | Comprehensive Cancer Centre The Netherlands | 2015-09-01 |
| Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer (NCT02549989) | Memorial Sloan Kettering Cancer Center | 2015-09-01 |
| Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors (NCT02684318) | Poveda, Andrés, M.D. | 2015-07-01 |
| Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole (NCT02476955) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2015-06-09 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer (NCT02117817) | Rutgers, The State University of New Jersey | 2015-02-01 |
| Effect of Fertility-sparing Therapy of Early Endometrial Cancer (NCT03538704) | Peking University People's Hospital | 2015-01-01 |
| Exercise as an Intervention in Endometrial Cancer Survivors (NCT02367950) | Royal Cornwall Hospitals Trust | 2015-01-01 |
| Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer (NCT02285192) | Memorial Sloan Kettering Cancer Center | 2014-11-01 |
| Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers (NCT02269293) | Memorial Sloan Kettering Cancer Center | 2014-10-13 |
| A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer (NCT02127151) | University College, London | 2014-10-01 |
| Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors (NCT02262455) | Santa Maria Biotherapeutics | 2014-10-01 |
| 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial (NCT02320565) | Catholic University of the Sacred Heart | 2014-10-01 |
| Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion (NCT01979003) | University of Arkansas | 2014-09-01 |
| Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer (NCT02096783) | University of Wisconsin, Madison | 2014-09-01 |
| Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy (NCT02058550) | Stanford University | 2014-09-01 |
| Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors (NCT02135562) | Case Comprehensive Cancer Center | 2014-08-08 |
| Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers (NCT02178722) | Incyte Corporation | 2014-07-17 |
| TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors (NCT02466061) | Fred Hutchinson Cancer Center | 2014-07-01 |
| Biomarkers for Gynecologic Cancer (NCT02178462) | Ajinomoto Co., Inc. | 2014-06-01 |
| 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy (NCT02091050) | AC Camargo Cancer Center | 2014-06-01 |
| BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers (NCT01550380) | University of Utah | 2014-05-01 |
| Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer (NCT02131558) | Lahey Clinic | 2014-05-01 |
| Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor (NCT02069158) | Cristiana Sessa | 2014-04-01 |
| Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients (NCT02035787) | UNC Lineberger Comprehensive Cancer Center | 2014-02-27 |
| Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System (NCT04817501) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2014-02-14 |
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (NCT02042885) | Otsuka Novel Products GmbH | 2014-01-01 |
| Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer (NCT04246580) | Università degli Studi dell'Insubria | 2014-01-01 |
| DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics (NCT02288676) | McGill University | 2014-01-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma (NCT01797523) | M.D. Anderson Cancer Center | 2013-10-07 |
| Lymphedema in Endometrial Cancer (NCT01914276) | Duke University | 2013-10-01 |
| Hula, a Physical Activity Intervention for Female-Cancer Survivors (NCT02351479) | University of Hawaii | 2013-09-01 |
| Screening for Endometrial Abnormalities in Overweight and Obese Women (NCT01922778) | St. Luke's-Roosevelt Hospital Center | 2013-09-01 |
| Factors Affecting the Prognosis of Patients With Endometrial Cancer (NCT01886040) | Far Eastern Memorial Hospital | 2013-06-01 |
| OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer (NCT01961102) | Krankenhaus Barmherzige Schwestern Linz | 2013-05-01 |
| Follow-up of Endometrial Cancer Patients (NCT01853865) | Odense University Hospital | 2013-05-01 |
| Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer (NCT01767155) | AEterna Zentaris | 2013-04-01 |
| PET-CT vs. Integrated MR-PET Scanning of GYN Cancers (NCT01779128) | Massachusetts General Hospital | 2013-03-01 |
| Lymph Node Mapping in Patients With Endometrial Cancer (NCT01818739) | Ohio State University Comprehensive Cancer Center | 2013-03-01 |
| Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples (NCT01793545) | National Cancer Institute (NCI) | 2013-02-11 |
| Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics (NCT01761721) | Copenhagen University Hospital at Herlev | 2013-01-01 |
| Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer (NCT01679522) | Asan Medical Center | 2013-01-01 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health (NCT01738152) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer (NCT01672892) | Radiation Therapy Oncology Group | 2012-11-01 |